News Highlights: Top Company News of the Day
May 21 2019 - 5:30PM
Dow Jones News
Mallinckrodt Stock Falls Sharply After a Warning Over Regulatory Dispute
The drugmaker lost over one-quarter of its stock-market value
after the company said a dispute with health regulators might cost
it $600 million and reduce future sales for Acthar, one of its
top-selling products.
Apple Changes MacBook Butterfly Keyboard After User Complaints
After customers reported issues with three generations of its
Mac laptop keyboard, Apple is changing a component material and
expanding its keyboard repair program.
Medical-Testing Company Trident Faces Whistleblower Challenge
Mobile medical-testing provider Trident Holding Co. is trying to
emerge from bankruptcy, but it is facing the threat of continued
legal trouble with the U.S. government over allegations it paid
kickbacks to build its business.
Terrible Tuesday for Department Stores
Kohl's and J.C. Penney reported disappointing quarterly results,
setting off a tumble in the department-store sector.
Huawei Accuses U.S. of Bullying as It Seeks Support From Europe
Huawei denounced U.S. actions against the company as "bullying"
and implored European governments to resist American pressure to
follow suit in a bid to safeguard one of its most lucrative
markets.
Wall Street Is Losing Faith in Tesla
As Tesla's shares drop, once-bullish analysts and investors are
souring on Elon Musk's company, potentially cutting it off from the
capital it needs to survive.
Home Depot's Sales Lifted by Larger Customer Transactions
Home Depot's sales rose in the fiscal first quarter, lifted by a
rise in the number of customer transactions and stronger spending
per visit.
'Stranger Things' Brings Back New Coke. Sort of.
Coca-Cola is using one of its biggest failures as a marketing
tool, bringing back New Coke for a limited time in a
cross-promotion with Netflix's retro science-fiction horror series
"Stranger Things."
PPG Says It Won't Break Up, Despite Pressure From Activist Investor
PPG Industries won't split its units making building paints and
industrial coatings, choosing to forge ahead as a unified company
after facing pressure from an activist investor to maximize value
in its disparate operations.
Merck to Buy Cancer Drug Maker Peloton Therapeutics
Merck agreed to acquire cancer drug developer Peloton
Therapeutics for $1.05 billion in cash, adding to a list of deals
in 2019 by pharmaceutical companies looking to bolster their cancer
treatment portfolios.
(END) Dow Jones Newswires
May 21, 2019 17:15 ET (21:15 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.